SIE

209.8

+4.98%↑

AIR.FR

163.78

+3.53%↑

ENR.DE

147.9

+8%↑

RHM

1,467.5

+1.28%↑

HO

237.7

+1.11%↑

SIE

209.8

+4.98%↑

AIR.FR

163.78

+3.53%↑

ENR.DE

147.9

+8%↑

RHM

1,467.5

+1.28%↑

HO

237.7

+1.11%↑

SIE

209.8

+4.98%↑

AIR.FR

163.78

+3.53%↑

ENR.DE

147.9

+8%↑

RHM

1,467.5

+1.28%↑

HO

237.7

+1.11%↑

SIE

209.8

+4.98%↑

AIR.FR

163.78

+3.53%↑

ENR.DE

147.9

+8%↑

RHM

1,467.5

+1.28%↑

HO

237.7

+1.11%↑

SIE

209.8

+4.98%↑

AIR.FR

163.78

+3.53%↑

ENR.DE

147.9

+8%↑

RHM

1,467.5

+1.28%↑

HO

237.7

+1.11%↑

Search

Teleperformance SE

Uždarymo kaina

SektoriusPramonės sektorius

49.54 -3.81

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

48.51

Max

51.26

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-1M

248M

Pardavimai

-23M

5.1B

P/E

Sektoriaus vid.

6.064

61.065

Dividendų pajamingumas

8.78

Pelno marža

4.869

Darbuotojai

446,716

EBITDA

99M

988M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+56.56% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

8.78%

2.23%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

42M

3B

Ankstesnė atidarymo kaina

53.35

Ankstesnė uždarymo kaina

49.54

Naujienos nuotaikos

By Acuity

80%

20%

387 / 406 reitingas Industrials

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Teleperformance SE Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-23 23:47; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

2026-03-23 22:55; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

2026-03-23 21:51; UTC

Įsigijimai, susijungimai, perėmimai

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

2026-03-23 23:59; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-23 23:59; UTC

Rinkos pokalbiai

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

2026-03-23 23:50; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

2026-03-23 23:37; UTC

Rinkos pokalbiai

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Equities Roundup: Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

2026-03-23 22:40; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

2026-03-23 22:23; UTC

Rinkos pokalbiai

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

2026-03-23 22:22; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

2026-03-23 22:18; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

2026-03-23 22:15; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

2026-03-23 22:08; UTC

Rinkos pokalbiai

Ebos Needs to Reset Its Gearing Targets -- Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

2026-03-23 21:10; UTC

Svarbiausios naujienos

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

2026-03-23 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai
Uždarbis
Svarbiausios naujienos

Basic Materials Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Teleperformance SE Prognozė

Kainos tikslas

By TipRanks

56.56% į viršų

12 mėnesių prognozė

Vidutinis 80 EUR  56.56%

Aukščiausias 115 EUR

Žemiausias 50 EUR

Remiantis 6 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Teleperformance SE kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

6 ratings

3

Pirkti

3

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

91.28 / 94.3Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

Strong Bearish Evidence

Rinkos nuotaikos

By Acuity

387 / 406 reitingas Pramonės sektorius

Naujienos nuotaikos

Labai stiprus meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Teleperformance SE

Teleperformance SE, together with its subsidiaries, engages in the customers consultancy services in France and internationally. The company operates in two segments, Core Services and Digital Integrated Business Services, and Specialized Services. The company offers customer relationship operations, technical support, technical assistance and customer acquisition services, management of business processes, back office and digital platform services, consulting, data analysis services, on-line interpretation, visa application management, health management services, and accounts receivable credit management services, and recruitment process outsource services. It also provides digital CX, trust and safety, artificial intelligence, video CX, metaverse, CX management, advanced analytics, business transformation consulting, technology as a service, collection service, interpretation and translation, and healthcare support services. The company serves automotive, energy and utilities, insurance, government, technology, travel and hospitality, and banking and financial services, as well as healthcare, media, retail and e-commerce, cargo, telecom, and video games industries. Teleperformance SE was incorporated in 1910 and is headquartered in Paris, France.
help-icon Live chat